Search
for
Sort by
Research 451–480 of 1000+
- LC-MS/MS improves screening towards 21-hydroxylase deficiency
- Alopecia with male-pattern androgenetic alopecia linked to an adrenal tumor: a case report
- Is polycystic ovary syndrome a sexual conflict? A review
- Managing Acne in Individuals with Polycystic Ovarian Syndrome
- Molecular Aspects of Polycystic Ovarian Syndrome in Female Population in Karnataka at the Southwestern Region of India
- Dermatologic manifestations in patients with polycystic ovary syndrome: their prevalence and assessment in relation to hormonal and metabolic changes
- Study of cutaneous manifestations in patients with polycystic ovarian syndrome attending a tertiary care centre
- Approaches to lifestyle management in polycystic ovary syndrome
- 9 Diagnosis and therapy of hyperandrogenism
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Abstract 152
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS
- Polycystic ovary syndrome and estroprogestins
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Beyond Boundaries: The Transformative Potential of Spironolactone in Female Pattern Hair Loss
- Diagnosis of Polycystic Ovary Syndrome
- Changes in the PCOS phenotype with age
- DERMATOLOGICAL ASPECTS OF SIGNIFICANCE OF HYPERANDROGENIZM FOR POLYCYSTIC OVARY SYNDROME
- EFFECT OF METFORMIN THERAPY IN FEMALE VISITING DERMATOLOGIST FOR ACNE VULGARIS HAVING ENDOCRINE AND SONOGRAPHIC CHARACTERISTICS OF POLYCYSTIC OVARY SYNDROME (PCOS)
- ROLE OF METFORMIN IN POLYCYSTIC OVARIAN SYNDROME
- THE IMPACT OF LIFESTYLE: THE EFFECTS OF DIET, EXERCISE AND INOSITOL SUPPLEMENTATION ON THE COURSE OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME (PMOS): NARRATIVE REVIEW
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Management of “hyperandrogenism” confounded by dermatology biotin prescriptions
- SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Diagnosis of hyperandrogenism: Biochemical criteria